1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Imaging modalities for all 9 patients before and after rupture, with the time between imaging before and after rupture and the days between hemorrhage and imaging after rupture^{^a}
Pt Imaging Modality before Rupture Resolution (mm) Imaging Modality after Rupture Resolution (mm) Time between Imaging before and after Rupture Days between Hemorrhage and Imaging after Rupture
1 3D TOF MRA 0.49 × 0.49 × 1.2 3DRA 0.22 × 0.22 × 0.22 0 yr, 183 days 1
2 3D TOF MRA 0.31 × 0.31 × 1.0 CTA 0.31 × 0.31 × 0.45 0 yr, 72 days 1
3 CTA 0.33 × 0.33 × 1.0 CTA 0.35 × 0.35 × 0.33 2 yr, 323 days 2
4 3D PC MRA 0.78 × 0.78 × 1.0 3DRA 0.25 × 0.25 × 0.25 0 yr, 151 days 0
5 3D TOF MRA 0.45 × 0.45 × 1.0 3DRA 0.39 × 0.39 × 0.39 3 yr, 148 days 0
6 CTA 0.43 × 0.43 × 0.9 3DRA 0.22 × 0.22 × 0.22 0 yr, 34 days 0
7 3D TOF MRA 0.20 × 0.20 × 1.0 3DRA 0.17 × 0.17 × 0.17 4 yr, 1 day 3
8 3D TOF MRA 0.35 × 0.35 × 1.4 3DRA 0.17 × 0.17 × 0.17 0 yr, 14 days 9
9 CTA 0.33 × 0.33 × 1.3 3DRA 0.09 × 0.09 × 0.09 0 yr, 302 days 2
Note:—Pt indicates patient; PC, phase-contrast.
↵a Table adapted from Schneiders et al.¹⁴